Schonfeld Strategic Advisors »

Eliem Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.6M 126k 13.04
2025-03-31 $540k 443k 1.22
2024-12-31 $837k 465k 1.80

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Micron Technology (MU)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Msci Brazil Etf (EWZ)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Amazon (AMZN)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vale S A Sponsored Ads (VALE)
Petroleo Brasileiro S A Sponsored Adr (PBR)

View all positions for Schonfeld Strategic Advisors

Top funds holding Eliem Therapeutics

RA Capital Management
FMR
UBS Group
Braidwell
Adage Capital Partners GP
BlackRock
Cormorant Asset Management
Frontier Capital Management
T. Rowe Price Associates
Vanguard Capital Management
Woodline Partners
Citadel Advisors
Redmile Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors

View all funds holding Eliem Therapeutics